Transbronchial MWA for Pulmonary Tumors
The purpose of the study is to evaluate the efficacy and safety of transbronchial microwave ablation for lung cancer.
| Condition(s) | Lung Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The purpose of the study is to evaluate the efficacy and safety of transbronchial microwave ablation for lung cancer. |
| Who can participate | Inclusion Criteria: 1. Age ≥18 years old; 2. Pathologically diagnosed as primary peripheral lung cancer, preoperative staging suggested clinical staging as T1N0M0, stage IA (including new-onset lung cancer after surgery and multiple primary lung cancer). Or it is a metastatic lung tumor, the primary lesion has been completely resected, and the maximum diameter of the tumor is ≤3cm, the number of tumors requiring intervention is ≤3. 3. The lesion to be ablated has been evaluated as feasible for microwave ablation treatment under bronchoscopy guidance. 4. Agree to undergo transbronchial MWA as initial treatment after being assessed unsuitable for surgery and radiotherapy or refusing surgery and radiotherapy, and sign informed consent. Exclusion Criteria: 1. Diffuse lesions in both lungs, for |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Shanghai Chest Hospital |
| Locations | Shanghai, Shanghai Municipality, China |
| Start date | 2025-05-12 |
| NCT ID | NCT06969014 |
| Official listing | https://clinicaltrials.gov/study/NCT06969014 |